Cyclacel Pharmaceuticals
Permanently closed
200 Connell Dr Ste 1500
Berkeley Heights, NJ 07922
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company based in Berkeley Heights, NJ, focused on developing innovative cancer medicines through the exploration of cell cycle transcriptional regulation, epigenetics, and mitosis biology. The company aims to address oncology and hematology indications by building a diversified pipeline of novel drug candidates that target mechanisms of resistance in cancer cells.
As a pioneer in cell cycle biology, Cyclacel is dedicated to reactivating the body's own cell death mechanisms to combat cancer. Currently, the company has two orally available programs in clinical development: Fadraciclib, a CDK2 and CDK9 inhibitor, and Plogosertib, a PLK1 inhibitor.
Generated from the website
Also at this address
See a problem?
